U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.87
    +0.44 (+0.41%)
     
  • Gold

    1,807.00
    +5.50 (+0.31%)
     
  • Silver

    19.78
    +0.12 (+0.60%)
     
  • EUR/USD

    1.0458
    +0.0032 (+0.30%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • GBP/USD

    1.2154
    +0.0051 (+0.42%)
     
  • USD/JPY

    135.3260
    +0.1510 (+0.11%)
     
  • BTC-USD

    19,496.77
    +397.05 (+2.08%)
     
  • CMC Crypto 200

    420.89
    +0.75 (+0.18%)
     
  • FTSE 100

    7,251.37
    +82.72 (+1.15%)
     
  • Nikkei 225

    26,153.81
    +218.19 (+0.84%)
     

U.S. FTC launches inquiry into drug middlemen

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

June 7 (Reuters) - The Federal Trade Commission said on Tuesday it will launch an inquiry into the prescription drug middleman industry, sending compulsory orders to six pharmacy benefit managers for records on their business practices.

As part of the inquiry, the antitrust body will send orders to CVS Health Corp's Caremark, Humana Inc, Cigna Corp's Express Scripts and UnitedHealth Group's OptumRx, among others. (Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri)